Skip to main content
Sister Publication Links
  • ModernHealthcare.com
Subscribe
  • My Account
  • Login
  • Register
  • Consumer Centric
  • Provider/Payer Centric
  • Funding/M&A
  • Policy
  • Data
  • Opinion
  • MORE+
    • Webinars
    • Advertise
MENU
Breadcrumb
  1. Home
  2. Finance
August 30, 2022 06:17 PM

Oscar Health loses big customer

Nona Tepper
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    OscarOffice_i.jpg
    Carla Tramullas

    Oscar Health’s first full-service technology deal has ended before it really got off the ground.

    Health First Shared Services, a Florida-based not-for-profit integrated provider and insurer,  “has indicated that it intends to terminate the agreement and transition the services from +Oscar to HF, effective as early as January 1, 2023,” Oscar Health disclosed in a Securities and Exchange Commission filing Tuesday. 

    Health First represented the first customer to completely and publicly buy in to Oscar Health’s technology services. The insurtech had aimed to ink two such technology deals each year. 

    Oscar Health’s deal with the insurer was expected to generate $60 million in revenue in 2022, the filing said. Terminating the agreement will not have a material impact on the company’s net loss and adjusted earnings before income, taxes, depreciation and amortization in 2022, according to the filing. 

    The two companies announced the partnership in January 2021. Oscar Health agreed to provide Health First's Medicare Advantage and individual policyholders access to the insurtech’s member engagement, provider and broker services.

    Oscar Health and Health First did not immediately respond to interview requests. 

    The services were set to go live at the beginning of the year but during a second-quarter earnings call earlier this month, Oscar Health CEO Mario Schlosser said the company was addressing "post-launch challenges that we are experiencing due to the complexity of a comprehensive integration at this scale."

    During that call, Schlosser listed the challenges as one reason for pausing similar, full-service technology deals for the next 18 months. Schlosser also said the company would hold off on similar deals to focus on achieving profitability in its insurance arm by next year.

    “We certainly remain committed to the Plus Oscar business,” Schlosser said during the call. 

    Oscar Health reported a net loss of $112.1 million on revenues of $1 billion during the second quarter. 

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it online.

    Recommended for You
    Alyssa Jaffee
    Five Questions: 7wireVentures’ Alyssa Jaffee
    money2_i_i.png
    GeneDx to raise $150M in public and direct stock offerings
    Sponsored Content
    Get Newsletters

    Newsletters for providers, payers, investors and innovators across the digital health ecosystem. Sign up to get breaking digital health news including digital health deals, M&A, finance, IPOs. as they happen, right to your inbox.

    Buy Q3 Report Today
    Quarterly Report Cover Image

    The Digital Health Funding and M&A Q3 report delivers the most comprehensive insight and data around the financial health of the sector.

    Purchase Today
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Digital Health Business & Technology delivers news, data, insights and analysis covering the entire digital healthcare ecosystem.

    Logo
    Contact Us

    (877) 812-1581

    Email us

     

    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    Resources
    • About Us
    • Contact Us
    • Staff
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Digital Health Business & Technology
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • Consumer Centric
    • Provider/Payer Centric
    • Funding/M&A
    • Policy
    • Data
    • Opinion
    • MORE+
      • Webinars
      • Advertise